Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06539247
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
MRP Verses PNF On Pain Foot Drop Gait And Functional Mobility In Hemiplegic Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparative Effects of Motor Relearning Approach Verses Proprioceptive Neuromuscular Facilitation Technique PNF on Pain Foot Drop Gait and Functional Mobility in Hemiplegic Patients
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CEMRA-PNF
Brief Summary:
This single blinded randomized control study aims to determine the comparative effectiveness of two rehabilitation approaches for improving pain foot drop gait and functional mobility in patients with hemiplegia The study will recruit 68 patients diagnosed with hemiplegia who meet specific inclusion criteria Both groups will receive a treatment program lasting eight weeks with assessments at baseline week four and week eight The study will measure various outcomes as gait analysis foot drop grading functional ability and pain assessment This study aims to contribute to evidence-based practice in stroke rehabilitation by comparing the effectiveness of motor relearning and PNF approaches for improving gait pain and functional mobility in hemiplegic patients The findings may help guide therapists in selecting the most appropriate intervention for individual patients
Detailed Description:
Stroke is a leading cause of disability worldwide with hemiplegia muscle weakness or paralysis on one side of the body being a common consequence Rehabilitation plays a crucial role in improving gait reducing pain and enhancing functional mobility for stroke patients This study investigates the comparative effects of two rehabilitation approaches Motor Relearning MRP and Proprioceptive Neuromuscular Facilitation PNF
Study Design This is a randomized controlled trial with two parallel groups
Group A Motor Relearning Approach with Electrical Muscle Stimulation EMS Group B Proprioceptive Neuromuscular Facilitation Technique PNF with Electrical Muscle Stimulation EMS
Randomization Eligible participants will be randomly assigned to either group using a lottery method to ensure balance between groups
Blinding The assessor evaluating outcomes will be blinded to group allocation single-blinded
Intervention Both groups will receive an eight-week intervention program with assessments at baseline week four and week eight Each session will last approximately 30 minutes
Group A MRP with EMS Participants will perform motor relearning exercises targeting foot drop and gait patterns EMS will be integrated during specific exercises for targeted muscle activation
Group B PNF with EMS Participants will receive PNF techniques designed to improve neuromuscular facilitation for gait and foot clearance EMS will be used alongside PNF exercises to enhance muscle response
Progress Monitoring Treatment intensity and exercise difficulty will be progressively adjusted for both groups throughout the intervention based on participant tolerance and progress
Ethical Considerations This study has received ethical approval from the Institutional Review Board IRB Informed consent will be obtained from all participants
Data Analysis Statistical software will be used to analyze the data with appropriate tests employed based on data normality to compare outcomes between groups
Expected Outcomes It is anticipated that this study will provide valuable insights into the relative effectiveness of MRP and PNF approaches for improving gait pain management and functional mobility in patients with hemiplegia The findings can contribute to evidence-based practice in stroke rehabilitation and guide therapists in selecting the most suitable intervention for individual patient needs
Study Design This is a randomized controlled trial with two parallel groups
Group A Motor Relearning Approach with Electrical Muscle Stimulation EMS Group B Proprioceptive Neuromuscular Facilitation Technique PNF with Electrical Muscle Stimulation EMS
Randomization Eligible participants will be randomly assigned to either group using a lottery method to ensure balance between groups
Blinding The assessor evaluating outcomes will be blinded to group allocation single-blinded
Intervention Both groups will receive an eight-week intervention program with assessments at baseline week four and week eight Each session will last approximately 30 minutes
Group A MRP with EMS Participants will perform motor relearning exercises targeting foot drop and gait patterns EMS will be integrated during specific exercises for targeted muscle activation
Group B PNF with EMS Participants will receive PNF techniques designed to improve neuromuscular facilitation for gait and foot clearance EMS will be used alongside PNF exercises to enhance muscle response
Progress Monitoring Treatment intensity and exercise difficulty will be progressively adjusted for both groups throughout the intervention based on participant tolerance and progress
Ethical Considerations This study has received ethical approval from the Institutional Review Board IRB Informed consent will be obtained from all participants
Data Analysis Statistical software will be used to analyze the data with appropriate tests employed based on data normality to compare outcomes between groups
Expected Outcomes It is anticipated that this study will provide valuable insights into the relative effectiveness of MRP and PNF approaches for improving gait pain management and functional mobility in patients with hemiplegia The findings can contribute to evidence-based practice in stroke rehabilitation and guide therapists in selecting the most suitable intervention for individual patient needs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None